Sinovac Receives Clinical Trial Approval for Varicella; FDA Approves BELBUCA Buccal Film Print E-mail
By Josh Gee   
Monday, 26 October 2015 19:05
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 26, 2015.          
Read more...
 
Amgen Receives CHMP Positive Opinion For IMLYGIC™; Spectrum Receives CRL from FDA for EVOMELA Print E-mail
By Mary Davila   
Friday, 23 October 2015 19:28
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 23, 2015.     
Read more...
 
Merrimack Confirms U.S. FDA Approval of ONIVYDE(TM); CardioCell Utilizes BioLife's CryoStor® in Phase II Clinical Trial for Heart Failure Print E-mail
By Mary Davila   
Thursday, 22 October 2015 19:40
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 22, 2015.
Read more...
 
Gilead Provides Update on Investigational Compound, GS-5734; PositiveID Enters Into Agreement to Acquire Thermomedics Print E-mail
By Josh Gee   
Wednesday, 21 October 2015 18:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 21, 2015.    
Read more...
 
Kite Pharma Announces Exclusive License with the National Institutes of Health for T Cell Receptor; RXi Pharma Announces Positive Results with Novel Self-Delivering RNAi Platform Print E-mail
By Mary Davila   
Tuesday, 20 October 2015 19:01
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 20, 2015.
Read more...
 
RXi Pharma Announces Positive Interim Results in Phase 2a RXI-109; Cerulean Announces Completion of Enrollment of Randomized Phase 2 Trial of CRLX101 Print E-mail
By William Kent   
Thursday, 15 October 2015 19:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 15, 2015.     
Read more...
 
Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ®; Ampio Announces Updates On the Regulatory Path for FDA Approval of Optina™ Print E-mail
By Marilyn Mullen   
Wednesday, 14 October 2015 19:24
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 14, 2015.         
Read more...
 
Threshold Pharma Receives Two U.S. Patents for Tarloxotinib Bromide; Portola Announces FDA Grants Fast Track Designation to Betrixaban Print E-mail
By Josh Gee   
Tuesday, 13 October 2015 19:28
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 13, 2015.     
Read more...
 
Pfizer's Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA®; FDA Accepts Supplemental New Drug Application for DALVANCE® Print E-mail
By William Kent   
Friday, 09 October 2015 18:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 9, 2015.     
Read more...
 
Aduro Receives Milestone Payment From Janssen for ADU-214; OncoGenex Announces EMA Support for Phase 3 AFFINITY Trial Print E-mail
By David Fowler   
Thursday, 08 October 2015 18:47
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 8, 2015.   
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 2 of 369

Newsletter